Ghndp Medicines Price Data

The Government of Ghana, through the National Medicine Policy,

remains committed to ensuring the availability of and accessibility to,

affordable and good quality medicines for all Ghanaians; and it is expected

that these medicines would be used rationally. Achieving these objectives

require a comprehensive strategy that not only includes supply and

distribution, but also appropriate and thoughtful prescribing, dispensing

and use of medicines.

The Ministry of Health since 1983 has been publishing a list of

Essential Drugs with Therapeutic Guidelines to aid the rational use of

drugs. This document has been reviewed in response to new knowledge

on drugs and diseases and changes in the epidemiology of diseases in

Ghana. The Ministry has also produced guidelines for specific disease

control programs, diseases and identifiable health providers.

The Standard Treatment Guidelines have been prepared as a tool

to assist and guide prescribers (including doctors, medical assistants,

and midwives), pharmacists, dispensers, and other healthcare staff who

prescribe at primary care facilities in providing quality care to patents.

The guidelines list the preferred treatments for common health problems

experienced by people in the health system and were subjected to

stakeholder discussions before being finalized to ensure that the opinion

of the intended users were considered and incorporated.

The guidelines are designed to be used as a guide to treatment

choices and as a reference book to help in the overall management of

patents, such as when to refer. The guidelines are meant for use at all

levels within the health system, both public and private.

It is recognized that the treatment guidance detailed in this book may

differ from current practice. It is emphasized that the choices described

here have the weight of scientific evidence to support them, together

with the collective opinion of a wide group of recognized national and

international experts. The recommendations have been rated on the

following basis:

Evidence Rating A – requires at least one randomized control trial

as part of a body of scientific literature of overall good quality and

consistency addressing the specific recommendation.